Tag

Here you will find all the news, press releases and publications on this theme, listed in chronological order. You can find our dossiers on the various themes at www.publiceye.ch/topics

Novartis

Big pharma Price of medicines: walls of abusive patents are standing in the way of competition

30. August 2024

Abusive patenting Novartis & Co are using their “evergreening” practice to rip off the Swiss population, too

30. August 2024

40 to 90 percent profit margins Astronomical profit margins of pharmaceutical companies are partly to blame for the premium shock

12. September 2022

Report Big Pharma takes it all

Patent abuse, lack of transparency, profiteering How Covid-19 exposes Big Pharma’s harmful business strategies

9. March 2021

Affordable drugs How dare you, Novartis?

28. February 2020

Affordable drugs Novartis cancer treatment for CHF 370,000?! Public Eye opposes Kymriah patent

3. July 2019

Clinical trials Roche and Novartis neglect their ethical responsibility in emerging countries

20. May 2019

News Glivec in Colombia: new leaked letter from Novartis attests to pressure at highest level

11. December 2015

Press Release Compulsory licensing in Colombia: Aggressive lobbying by Novartis

18. August 2015